Literature DB >> 32838318

Anakinra for severe forms of COVID-19.

Laine Marc1,2, Bonello Laurent1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32838318      PMCID： PMC7413647          DOI： 10.1016/S2665-9913(20)30272-1

Source DB:  PubMed          Journal:  Lancet Rheumatol        ISSN： 2665-9913


× No keyword cloud information.
  3 in total

1.  Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence.

Authors:  Julien Poissy; Julien Goutay; Morgan Caplan; Erika Parmentier; Thibault Duburcq; Fanny Lassalle; Emmanuelle Jeanpierre; Antoine Rauch; Julien Labreuche; Sophie Susen
Journal:  Circulation       Date:  2020-04-24       Impact factor: 29.690

2.  Anakinra for severe forms of COVID-19: a cohort study.

Authors:  Thomas Huet; Hélène Beaussier; Olivier Voisin; Stéphane Jouveshomme; Gaëlle Dauriat; Isabelle Lazareth; Emmanuelle Sacco; Jean-Marc Naccache; Yvonnick Bézie; Sophie Laplanche; Alice Le Berre; Jérôme Le Pavec; Sergio Salmeron; Joseph Emmerich; Jean-Jacques Mourad; Gilles Chatellier; Gilles Hayem
Journal:  Lancet Rheumatol       Date:  2020-05-29

3.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.

Authors:  Ning Tang; Huan Bai; Xing Chen; Jiale Gong; Dengju Li; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-04-27       Impact factor: 5.824
  3 in total
  1 in total

1.  Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.

Authors:  Carl Randall Harrell; Biljana Popovska Jovicic; Valentin Djonov; Vladislav Volarevic
Journal:  Anal Cell Pathol (Amst)       Date:  2020-11-20       Impact factor: 2.916
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.